Literature DB >> 21356481

Diffusion and diffusion tensor imaging in brain cancer.

Elizabeth R Gerstner1, A Gregory Sorensen.   

Abstract

Conventional magnetic resonance imaging provides important information on the structure of tumors, but new imaging tools are emerging that provide more detailed functional information on tumor biology. In particular, diffusion-weighted imaging (DWI) is sensitive to the tumor microenvironment so it may serve as a prognostic biomarker and an indicator of tumor response to chemoradiation. Furthermore, DWI and diffusion tensor imaging may play a role in radiation planning and assessing the long-term effects of radiation. DWI is increasingly being incorporated into clinical practice and clinical trials, but more work needs to be done to standardize acquisition techniques and analysis methods of DWI.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21356481     DOI: 10.1016/j.semradonc.2010.10.005

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  18 in total

1.  Mean Diffusional Kurtosis in Patients with Glioma: Initial Results with a Fast Imaging Method in a Clinical Setting.

Authors:  A Tietze; M B Hansen; L Østergaard; S N Jespersen; R Sangill; T E Lund; M Geneser; M Hjelm; B Hansen
Journal:  AJNR Am J Neuroradiol       Date:  2015-05-14       Impact factor: 3.825

Review 2.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma.

Authors:  Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Kyrre E Emblem; Ovidiu Andronesi; Bruce Rosen
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

Review 3.  Diffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.

Authors:  Nathan S White; Carrie McDonald; Carrie R McDonald; Niky Farid; Josh Kuperman; David Karow; Natalie M Schenker-Ahmed; Hauke Bartsch; Rebecca Rakow-Penner; Dominic Holland; Ahmed Shabaik; Atle Bjørnerud; Tuva Hope; Jona Hattangadi-Gluth; Michael Liss; J Kellogg Parsons; Clark C Chen; Steve Raman; Daniel Margolis; Robert E Reiter; Leonard Marks; Santosh Kesari; Arno J Mundt; Christopher J Kane; Christopher J Kaine; Bob S Carter; William G Bradley; Anders M Dale
Journal:  Cancer Res       Date:  2014-09-01       Impact factor: 12.701

4.  Recovery of white matter tracts in regions of peritumoral FLAIR hyperintensity with use of restriction spectrum imaging.

Authors:  C R McDonald; N S White; N Farid; G Lai; J M Kuperman; H Bartsch; D J Hagler; S Kesari; B S Carter; C C Chen; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

Review 5.  Promise and pitfalls of quantitative imaging in oncology clinical trials.

Authors:  Brenda F Kurland; Elizabeth R Gerstner; James M Mountz; Lawrence H Schwartz; Christopher W Ryan; Michael M Graham; John M Buatti; Fiona M Fennessy; Edward A Eikman; Virendra Kumar; Kenneth M Forster; Richard L Wahl; Frank S Lieberman
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

6.  Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.

Authors:  Christine Lu-Emerson; Dan G Duda; Kyrre E Emblem; Jennie W Taylor; Elizabeth R Gerstner; Jay S Loeffler; Tracy T Batchelor; Rakesh K Jain
Journal:  J Clin Oncol       Date:  2015-02-23       Impact factor: 44.544

Review 7.  Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma.

Authors:  Fabrício Guimarães Gonçalves; Sanjeev Chawla; Suyash Mohan
Journal:  J Magn Reson Imaging       Date:  2020-03-19       Impact factor: 4.813

8.  Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of Cancer.

Authors:  Thomas E Yankeelov
Journal:  ISRN Biomath       Date:  2012

9.  Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors.

Authors:  L Klingelhöfer; D Mucha; K Geiger; R Koch; R von Kummer
Journal:  Clin Neuroradiol       Date:  2014-05-15       Impact factor: 3.649

Review 10.  Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?

Authors:  Shota Tanaka; David N Louis; William T Curry; Tracy T Batchelor; Jorg Dietrich
Journal:  Nat Rev Clin Oncol       Date:  2012-11-27       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.